chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site inflammation
Clinical narrative: Congestion; Vaccination site inflammation; Cough; Exposure to COVID-19; headache; This spontaneous case was reported by a consumer and describes the occurrence of NASAL CONGESTION (Congestion), VACCINATION SITE INFLAMMATION (Vaccination site inflammation ), COUGH (Cough), EXPOSURE TO SARS-COV-2 (Exposure to COVID-19) and HEADACHE (headache) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 091D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NASAL CONGESTION (Congestion), VACCINATION SITE INFLAMMATION (Vaccination site inflammation ), COUGH (Cough), EXPOSURE TO SARS-COV-2 (Exposure to COVID-19) and HEADACHE (headache). The patient was treated with IBUPROFEN for Vaccination site inflammation, at an unspecified dose and frequency. At the time of the report, NASAL CONGESTION (Congestion), VACCINATION SITE INFLAMMATION (Vaccination site inflammation ), COUGH (Cough), EXPOSURE TO SARS-COV-2 (Exposure to COVID-19) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Aug-2021, SARS-CoV-2 test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  The patient stated that he  had 15 COVID tests in the last 2 years and there were no positive results. The patient also stated that these symptoms will affect his cardiovascular capacity which will affect his job.
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: Shortness of breath; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (Shortness of breath). At the time of the report, DYSPNOEA (Shortness of breath) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided. Treatment information was not provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Chills, Dizziness, Dyspnoea, Headache
Clinical narrative: Difficulty breathing; Dizziness; Weakness; Chills; Fever; Nausea; headache/sharp pain in the back of the head; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Difficulty breathing), DIZZINESS (Dizziness), ASTHENIA (Weakness), CHILLS (Chills) and PYREXIA (Fever) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 078C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes, Blood pressure and Cholesterol. Concomitant products included LISINOPRIL for Blood pressure, METFORMIN for Diabetes.    On 27-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jul-2021, the patient experienced DYSPNOEA (Difficulty breathing), DIZZINESS (Dizziness), ASTHENIA (Weakness), CHILLS (Chills), PYREXIA (Fever), NAUSEA (Nausea) and HEADACHE (headache/sharp pain in the back of the head). The patient was treated with PARACETAMOL (TYLENOL EXTRA-STRENGTH) for Adverse event, at a dose of 1 dosage form and IBUPROFEN for Adverse event, at a dose of 1 dosage form. On 29-Jul-2021, DYSPNOEA (Difficulty breathing), DIZZINESS (Dizziness), ASTHENIA (Weakness), CHILLS (Chills), PYREXIA (Fever), NAUSEA (Nausea) and HEADACHE (headache/sharp pain in the back of the head) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products also included a medication for cholesterol.   Most recent FOLLOW-UP information incorporated above includes: On 01-Oct-2021: follow up document received contains no new information. On 08-Nov-2021: Follow-up document received, contains no new information.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pyrexia
Clinical narrative: Difficulty breathing; Dizziness; Weakness; Chills; Fever; Nausea; headache/sharp pain in the back of the head; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Difficulty breathing), DIZZINESS (Dizziness), ASTHENIA (Weakness), CHILLS (Chills) and PYREXIA (Fever) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 078C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes, Blood pressure and Cholesterol. Concomitant products included LISINOPRIL for Blood pressure, METFORMIN for Diabetes.    On 27-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jul-2021, the patient experienced DYSPNOEA (Difficulty breathing), DIZZINESS (Dizziness), ASTHENIA (Weakness), CHILLS (Chills), PYREXIA (Fever), NAUSEA (Nausea) and HEADACHE (headache/sharp pain in the back of the head). The patient was treated with PARACETAMOL (TYLENOL EXTRA-STRENGTH) for Adverse event, at a dose of 1 dosage form and IBUPROFEN for Adverse event, at a dose of 1 dosage form. On 29-Jul-2021, DYSPNOEA (Difficulty breathing), DIZZINESS (Dizziness), ASTHENIA (Weakness), CHILLS (Chills), PYREXIA (Fever), NAUSEA (Nausea) and HEADACHE (headache/sharp pain in the back of the head) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant products also included a medication for cholesterol.   Most recent FOLLOW-UP information incorporated above includes: On 01-Oct-2021: follow up document received contains no new information. On 08-Nov-2021: Follow-up document received, contains no new information.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: shingles; This spontaneous case was reported by a patient family member or friend and describes the occurrence of HERPES ZOSTER (shingles) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040B21A and 044A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Jul-2021, the patient experienced HERPES ZOSTER (shingles). At the time of the report, HERPES ZOSTER (shingles) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was reported.
Age: 15.0
Sex: M
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: 15 year old received Moderna COVID-19 vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15 year old received Moderna COVID-19 vaccine) in a 15-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15 year old received Moderna COVID-19 vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (15 year old received Moderna COVID-19 vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant and treatment medications were reported.
Sex: M
Vaccine: COVID19
Symptoms: Chest pain
Clinical narrative: Experienced chest pain 4 days after the vaccine; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CHEST PAIN (Experienced chest pain 4 days after the vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (Experienced chest pain 4 days after the vaccine). At the time of the report, CHEST PAIN (Experienced chest pain 4 days after the vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment medications were provided. Patient mentioned that his doctor told him that three cases especially in young male adults, they experienced same adverse event as chest pain after 4 days of vaccine administration.   Most recent FOLLOW-UP information incorporated above includes: On 01-Oct-2021: follow up received contains non-significant information.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Biopsy, Body temperature, Fatigue, Mobility decreased, Myalgia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain and soreness in left arm), MOBILITY DECREASED (could not move), FATIGUE (very tired), PYREXIA (fever) and MYALGIA (lot of body ache and muscle aches) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 031L20A) for COVID-19 vaccination. Concurrent medical conditions included Cancer (NOS). On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Mar-2021, the patient experienced PAIN IN EXTREMITY (Pain and soreness in left arm) and PYREXIA (fever). On an unknown date, the patient experienced MOBILITY DECREASED (could not move), FATIGUE (very tired) and MYALGIA (lot of body ache and muscle aches). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Pain and soreness in left arm), MOBILITY DECREASED (could not move), FATIGUE (very tired), PYREXIA (fever) and MYALGIA (lot of body ache and muscle aches) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Mar-2021, Biopsy: malignancy (abnormal) malignancy. On an unknown date, Body temperature: high (High) 102 degrees. No concomitant medication reported. 09Apri2021, patient started chemotherapy, Continuing since then. This case was linked to MOD-2021-276956 (Patient Link).
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain and soreness in left arm), MOBILITY DECREASED (could not move), FATIGUE (very tired), PYREXIA (fever) and MYALGIA (lot of body ache and muscle aches) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 031L20A) for COVID-19 vaccination. Concurrent medical conditions included Cancer (NOS). On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Mar-2021, the patient experienced PAIN IN EXTREMITY (Pain and soreness in left arm) and PYREXIA (fever). On an unknown date, the patient experienced MOBILITY DECREASED (could not move), FATIGUE (very tired) and MYALGIA (lot of body ache and muscle aches). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Pain and soreness in left arm), MOBILITY DECREASED (could not move), FATIGUE (very tired), PYREXIA (fever) and MYALGIA (lot of body ache and muscle aches) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Mar-2021, Biopsy: malignancy (abnormal) malignancy. On an unknown date, Body temperature: high (High) 102 degrees. No concomitant medication reported. 09Apri2021, patient started chemotherapy, Continuing since then. This case was linked to MOD-2021-276956 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis, Fatigue, Myalgia
Clinical narrative: When she blew her nose, it's bloody; Myalgia; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (When she blew her nose, it's bloody), MYALGIA (Myalgia) and FATIGUE (Fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included PREDNISONE and MELOXICAM for an unknown indication.    On 02-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EPISTAXIS (When she blew her nose, it's bloody), MYALGIA (Myalgia) and FATIGUE (Fatigue). At the time of the report, EPISTAXIS (When she blew her nose, it's bloody), MYALGIA (Myalgia) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided by the reporter.
Age: 59.0
Sex: U
Vaccine: COVID19
Symptoms: Osteoarthritis
Clinical narrative: osteoarthritis is going crazy; This spontaneous case was reported by a consumer and describes the occurrence of OSTEOARTHRITIS (osteoarthritis is going crazy) in a 59-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Osteoarthritis.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced OSTEOARTHRITIS (osteoarthritis is going crazy). At the time of the report, OSTEOARTHRITIS (osteoarthritis is going crazy) outcome was unknown. Concomitant medications were not provided. Treatment medications were not provided.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Osteoarthritis
Clinical narrative: osteoarthritis is going crazy; This spontaneous case was reported by a consumer and describes the occurrence of OSTEOARTHRITIS (osteoarthritis is going crazy) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Osteoarthritis.    In May 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced OSTEOARTHRITIS (osteoarthritis is going crazy). At the time of the report, OSTEOARTHRITIS (osteoarthritis is going crazy) outcome was unknown.            Concomitant product use was not provided by the reporter.   Treatment information was not provided.
Age: 59.0
Sex: U
Vaccine: COVID19
Symptoms: Osteoarthritis
Clinical narrative: osteoarthritis is going crazy; This spontaneous case was reported by a consumer and describes the occurrence of OSTEOARTHRITIS (osteoarthritis is going crazy) in a 59-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Osteoarthritis.   In May 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced OSTEOARTHRITIS (osteoarthritis is going crazy). At the time of the report, OSTEOARTHRITIS (osteoarthritis is going crazy) outcome was unknown.            No concomitant medications were reported No treatment medications were reported.   This case was linked to MOD21-126466, MOD21-126467, MOD21-126468 (Linked Report).   Reporter did not allow further contact; Sender's Comments:  MOD21-126466: MOD21-126467: MOD21-126468:
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: joint aches; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (joint aches) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037A21B and 047B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (joint aches). At the time of the report, ARTHRALGIA (joint aches) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medications or treatment details were reported.   Reporter did not allow further contact
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Myalgia
Clinical narrative: Sore arm; Tired; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Sore arm) and FATIGUE (Tired) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047A21A and 006C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYALGIA (Sore arm) and FATIGUE (Tired). At the time of the report, MYALGIA (Sore arm) and FATIGUE (Tired) outcome was unknown.            No concomitant medications or treatment details were reported.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Palpitations, Tachycardia
Clinical narrative: heart palpitations; tachycardia; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (heart palpitations) and TACHYCARDIA (tachycardia) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037B21A and 006B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PALPITATIONS (heart palpitations) and TACHYCARDIA (tachycardia). At the time of the report, PALPITATIONS (heart palpitations) and TACHYCARDIA (tachycardia) had not resolved.  No concomitant medications reported. It was reported that the patient was experiencing heart palpitations and tachycardia intermittently about 3-4 times a day, sometimes even when sitting. Patient reported monitoring the blood pressure with EKG machine (results not provided). Patient has no family history of myocarditis or pericarditis.  No treatment medication reported.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Headache, Influenza like illness
Clinical narrative: Flu like symptoms; Very tired; Severe headache; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), FATIGUE (Very tired) and HEADACHE (Severe headache) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), FATIGUE (Very tired) and HEADACHE (Severe headache). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), FATIGUE (Very tired) and HEADACHE (Severe headache) had resolved.            No concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 08-Sep-2021: Follow up contains no new information
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Dose administered after more than 30 days in refrigerator; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after more than 30 days in refrigerator) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after more than 30 days in refrigerator). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after more than 30 days in refrigerator) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication information was not reported.  Treatment information was not reported.   This case was linked to MOD-2021-267672 (Patient Link).
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Tremor, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: It is hot again; She started with itching at injection site; It is red again; It is swollen again; She had body shakes next day after receiving 1st dose; It was really hot; About 24 hours later, her left arm at injection site got swollen.; It was really red; It was really painful; She also had fever; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (She had body shakes next day after receiving 1st dose), VACCINATION SITE WARMTH (It was really hot), VACCINATION SITE WARMTH (It is hot again), VACCINATION SITE PRURITUS (She started with itching at injection site) and VACCINATION SITE SWELLING (About 24 hours later, her left arm at injection site got swollen.) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 091D21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information was provided.     On 28-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jul-2021, the patient experienced TREMOR (She had body shakes next day after receiving 1st dose), VACCINATION SITE WARMTH (It was really hot), VACCINATION SITE SWELLING (About 24 hours later, her left arm at injection site got swollen.), VACCINATION SITE ERYTHEMA (It was really red), VACCINATION SITE PAIN (It was really painful) and PYREXIA (She also had fever). On 05-Aug-2021, the patient experienced VACCINATION SITE WARMTH (It is hot again), VACCINATION SITE PRURITUS (She started with itching at injection site), VACCINATION SITE ERYTHEMA (It is red again) and VACCINATION SITE SWELLING (It is swollen again). The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 01-Aug-2021, VACCINATION SITE WARMTH (It was really hot), VACCINATION SITE SWELLING (About 24 hours later, her left arm at injection site got swollen.), VACCINATION SITE ERYTHEMA (It was really red) and VACCINATION SITE PAIN (It was really painful) had resolved. At the time of the report, TREMOR (She had body shakes next day after receiving 1st dose) and PYREXIA (She also had fever) had resolved and VACCINATION SITE WARMTH (It is hot again), VACCINATION SITE PRURITUS (She started with itching at injection site), VACCINATION SITE ERYTHEMA (It is red again) and VACCINATION SITE SWELLING (It is swollen again) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication included: Birth control
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site swelling, Vaccination site warmth
Clinical narrative: It is hot again; She started with itching at injection site; It is red again; It is swollen again; She had body shakes next day after receiving 1st dose; It was really hot; About 24 hours later, her left arm at injection site got swollen.; It was really red; It was really painful; She also had fever; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (She had body shakes next day after receiving 1st dose), VACCINATION SITE WARMTH (It was really hot), VACCINATION SITE WARMTH (It is hot again), VACCINATION SITE PRURITUS (She started with itching at injection site) and VACCINATION SITE SWELLING (About 24 hours later, her left arm at injection site got swollen.) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 091D21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history information was provided.     On 28-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jul-2021, the patient experienced TREMOR (She had body shakes next day after receiving 1st dose), VACCINATION SITE WARMTH (It was really hot), VACCINATION SITE SWELLING (About 24 hours later, her left arm at injection site got swollen.), VACCINATION SITE ERYTHEMA (It was really red), VACCINATION SITE PAIN (It was really painful) and PYREXIA (She also had fever). On 05-Aug-2021, the patient experienced VACCINATION SITE WARMTH (It is hot again), VACCINATION SITE PRURITUS (She started with itching at injection site), VACCINATION SITE ERYTHEMA (It is red again) and VACCINATION SITE SWELLING (It is swollen again). The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 01-Aug-2021, VACCINATION SITE WARMTH (It was really hot), VACCINATION SITE SWELLING (About 24 hours later, her left arm at injection site got swollen.), VACCINATION SITE ERYTHEMA (It was really red) and VACCINATION SITE PAIN (It was really painful) had resolved. At the time of the report, TREMOR (She had body shakes next day after receiving 1st dose) and PYREXIA (She also had fever) had resolved and VACCINATION SITE WARMTH (It is hot again), VACCINATION SITE PRURITUS (She started with itching at injection site), VACCINATION SITE ERYTHEMA (It is red again) and VACCINATION SITE SWELLING (It is swollen again) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication included: Birth control
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Product dose omission issue
Clinical narrative: Patient has received second dose of Moderna COVID-19 on 28May2021; Patient has not received second dose of Moderna; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient has received second dose of Moderna COVID-19 on 28May2021) and PRODUCT DOSE OMISSION ISSUE (Patient has not received second dose of Moderna) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 049C21A and 045A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure management and Hypercholesterolaemia. Concomitant products included TRAMADOL and DEXLANSOPRAZOLE (DEXILANT) for an unknown indication.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-May-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient has received second dose of Moderna COVID-19 on 28May2021). 28-May-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient has not received second dose of Moderna). On 28-May-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient has received second dose of Moderna COVID-19 on 28May2021) and PRODUCT DOSE OMISSION ISSUE (Patient has not received second dose of Moderna) had resolved.            Concomitant drug included some unknown medication for  blood pressure  and cholesterol .  Treatment medication was not reported.   This case was linked to MOD-2021-163762 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: have been given patients  vaccines that have been expire; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (have been given patients  vaccines that have been expire) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040b21a) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (have been given patients  vaccines that have been expire). At the time of the report, EXPIRED PRODUCT ADMINISTERED (have been given patients  vaccines that have been expire) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information not provided. List of concomitant medication were not given.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Missed the recommended interval inter doses; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Missed the recommended interval inter doses) in an adult patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed the recommended interval inter doses). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Missed the recommended interval inter doses) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment information provided.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Asthenia, Dizziness, Feeling abnormal, Injection site mass
Clinical narrative: Redness on upper left arm (vaccinated one); Itchiness on upper left arm (vaccinated one); Patient never got the second dose; Joint pain; Muscle pain; Bump in the injection site; Felt really bad at the time; Dizziness/Thought she was going to pass out or faint; Mild itchiness on the face down to the neck and different parts of the body/felt like having small ants biting; Weakness; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE MASS (Bump in the injection site), FEELING ABNORMAL (Felt really bad at the time), DIZZINESS (Dizziness/Thought she was going to pass out or faint), PRURITUS (Mild itchiness on the face down to the neck and different parts of the body/felt like having small ants biting) and ASTHENIA (Weakness) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jan-2021, the patient experienced FEELING ABNORMAL (Felt really bad at the time), DIZZINESS (Dizziness/Thought she was going to pass out or faint), PRURITUS (Mild itchiness on the face down to the neck and different parts of the body/felt like having small ants biting), ASTHENIA (Weakness) and NAUSEA (Nausea). On 14-Jan-2021, the patient experienced INJECTION SITE MASS (Bump in the injection site), ARTHRALGIA (Joint pain) and MYALGIA (Muscle pain). On 20-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness on upper left arm (vaccinated one)), VACCINATION SITE PRURITUS (Itchiness on upper left arm (vaccinated one)) and INTENTIONAL DOSE OMISSION (Patient never got the second dose). On 13-Jan-2021, FEELING ABNORMAL (Felt really bad at the time), DIZZINESS (Dizziness/Thought she was going to pass out or faint), PRURITUS (Mild itchiness on the face down to the neck and different parts of the body/felt like having small ants biting), ASTHENIA (Weakness) and NAUSEA (Nausea) had resolved. On 30-Jan-2021, INJECTION SITE MASS (Bump in the injection site), ARTHRALGIA (Joint pain), VACCINATION SITE ERYTHEMA (Redness on upper left arm (vaccinated one)), VACCINATION SITE PRURITUS (Itchiness on upper left arm (vaccinated one)) and MYALGIA (Muscle pain) had resolved. At the time of the report, INTENTIONAL DOSE OMISSION (Patient never got the second dose) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was withdrawn on an unknown date.       No treatment information was provided by the reporter.  No Concomitant medicines were reported.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Intentional dose omission, Myalgia, Nausea, Pruritus, Vaccination site erythema
Clinical narrative: Redness on upper left arm (vaccinated one); Itchiness on upper left arm (vaccinated one); Patient never got the second dose; Joint pain; Muscle pain; Bump in the injection site; Felt really bad at the time; Dizziness/Thought she was going to pass out or faint; Mild itchiness on the face down to the neck and different parts of the body/felt like having small ants biting; Weakness; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE MASS (Bump in the injection site), FEELING ABNORMAL (Felt really bad at the time), DIZZINESS (Dizziness/Thought she was going to pass out or faint), PRURITUS (Mild itchiness on the face down to the neck and different parts of the body/felt like having small ants biting) and ASTHENIA (Weakness) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jan-2021, the patient experienced FEELING ABNORMAL (Felt really bad at the time), DIZZINESS (Dizziness/Thought she was going to pass out or faint), PRURITUS (Mild itchiness on the face down to the neck and different parts of the body/felt like having small ants biting), ASTHENIA (Weakness) and NAUSEA (Nausea). On 14-Jan-2021, the patient experienced INJECTION SITE MASS (Bump in the injection site), ARTHRALGIA (Joint pain) and MYALGIA (Muscle pain). On 20-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness on upper left arm (vaccinated one)), VACCINATION SITE PRURITUS (Itchiness on upper left arm (vaccinated one)) and INTENTIONAL DOSE OMISSION (Patient never got the second dose). On 13-Jan-2021, FEELING ABNORMAL (Felt really bad at the time), DIZZINESS (Dizziness/Thought she was going to pass out or faint), PRURITUS (Mild itchiness on the face down to the neck and different parts of the body/felt like having small ants biting), ASTHENIA (Weakness) and NAUSEA (Nausea) had resolved. On 30-Jan-2021, INJECTION SITE MASS (Bump in the injection site), ARTHRALGIA (Joint pain), VACCINATION SITE ERYTHEMA (Redness on upper left arm (vaccinated one)), VACCINATION SITE PRURITUS (Itchiness on upper left arm (vaccinated one)) and MYALGIA (Muscle pain) had resolved. At the time of the report, INTENTIONAL DOSE OMISSION (Patient never got the second dose) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was withdrawn on an unknown date.       No treatment information was provided by the reporter.  No Concomitant medicines were reported.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus
Clinical narrative: Redness on upper left arm (vaccinated one); Itchiness on upper left arm (vaccinated one); Patient never got the second dose; Joint pain; Muscle pain; Bump in the injection site; Felt really bad at the time; Dizziness/Thought she was going to pass out or faint; Mild itchiness on the face down to the neck and different parts of the body/felt like having small ants biting; Weakness; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE MASS (Bump in the injection site), FEELING ABNORMAL (Felt really bad at the time), DIZZINESS (Dizziness/Thought she was going to pass out or faint), PRURITUS (Mild itchiness on the face down to the neck and different parts of the body/felt like having small ants biting) and ASTHENIA (Weakness) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025J20-2A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jan-2021, the patient experienced FEELING ABNORMAL (Felt really bad at the time), DIZZINESS (Dizziness/Thought she was going to pass out or faint), PRURITUS (Mild itchiness on the face down to the neck and different parts of the body/felt like having small ants biting), ASTHENIA (Weakness) and NAUSEA (Nausea). On 14-Jan-2021, the patient experienced INJECTION SITE MASS (Bump in the injection site), ARTHRALGIA (Joint pain) and MYALGIA (Muscle pain). On 20-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness on upper left arm (vaccinated one)), VACCINATION SITE PRURITUS (Itchiness on upper left arm (vaccinated one)) and INTENTIONAL DOSE OMISSION (Patient never got the second dose). On 13-Jan-2021, FEELING ABNORMAL (Felt really bad at the time), DIZZINESS (Dizziness/Thought she was going to pass out or faint), PRURITUS (Mild itchiness on the face down to the neck and different parts of the body/felt like having small ants biting), ASTHENIA (Weakness) and NAUSEA (Nausea) had resolved. On 30-Jan-2021, INJECTION SITE MASS (Bump in the injection site), ARTHRALGIA (Joint pain), VACCINATION SITE ERYTHEMA (Redness on upper left arm (vaccinated one)), VACCINATION SITE PRURITUS (Itchiness on upper left arm (vaccinated one)) and MYALGIA (Muscle pain) had resolved. At the time of the report, INTENTIONAL DOSE OMISSION (Patient never got the second dose) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was withdrawn on an unknown date.       No treatment information was provided by the reporter.  No Concomitant medicines were reported.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Myalgia, Pain in extremity
Clinical narrative: Arm hurts like a tetanus shot; Tired; Achy; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm hurts like a tetanus shot), FATIGUE (Tired) and MYALGIA (Achy) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm hurts like a tetanus shot), FATIGUE (Tired) and MYALGIA (Achy). At the time of the report, PAIN IN EXTREMITY (Arm hurts like a tetanus shot), FATIGUE (Tired) and MYALGIA (Achy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment information provided.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered, Product storage error
Clinical narrative: Expired vaccine dose administered to 2 patients/ expired vaccine dose; Vial was left out of fridge for more than 12 hours; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine dose administered to 2 patients/ expired vaccine dose) and PRODUCT STORAGE ERROR (Vial was left out of fridge for more than 12 hours) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 052E21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine dose administered to 2 patients/ expired vaccine dose) and PRODUCT STORAGE ERROR (Vial was left out of fridge for more than 12 hours). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine dose administered to 2 patients/ expired vaccine dose) and PRODUCT STORAGE ERROR (Vial was left out of fridge for more than 12 hours) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided.  No treatment information provided.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia oral, Tongue discomfort
Clinical narrative: After 2-3 hours, she felt some type of sensation in her tongue; Then it felt like burning in back side of the tongue; This spontaneous case was reported by a patient and describes the occurrence of PARAESTHESIA ORAL (After 2-3 hours, she felt some type of sensation in her tongue) and TONGUE DISCOMFORT (Then it felt like burning in back side of the tongue) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     Concomitant products included VITAMIN D [VITAMIN D NOS], L-CARNITINE [LEVOCARNITINE], UBIDECARENONE (CO Q-10) and FEXOFENADINE HYDROCHLORIDE (ALLEGRA) for an unknown indication.    On 04-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Aug-2021, the patient experienced PARAESTHESIA ORAL (After 2-3 hours, she felt some type of sensation in her tongue) and TONGUE DISCOMFORT (Then it felt like burning in back side of the tongue). At the time of the report, PARAESTHESIA ORAL (After 2-3 hours, she felt some type of sensation in her tongue) and TONGUE DISCOMFORT (Then it felt like burning in back side of the tongue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Other concomitant medications include Blood Pressure medicine, and Cholesterol Medicine. No treatment medications were reported
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (8 weeks since patient received first dose) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. Concomitant products included FAMOTIDINE (PEPCID [FAMOTIDINE]) for an unknown indication. On 11-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (8 weeks since patient received first dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (8 weeks since patient received first dose) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Reporter did not allow further contact.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Drooling, Dysarthria, Fatigue, Hyperhidrosis
Clinical narrative: right side of face is numb/The right side of me face is drooping; cannot close right eye all of the way; speech is slurred; excessive drooling from my mouth; Tiredness; tongue felt like I had burned it; tongue became numb; sweating; chills; fever; Sore left injection site Arm; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA ORAL (tongue became numb), HYPERHIDROSIS (sweating), TONGUE DISCOMFORT (tongue felt like I had burned it), HYPOAESTHESIA (right side of face is numb/The right side of me face is drooping) and OCULAR DISCOMFORT (cannot close right eye all of the way) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006D21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 02-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Aug-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VACCINATION SITE PAIN (Sore left injection site Arm). On 03-Aug-2021, the patient experienced HYPOAESTHESIA ORAL (tongue became numb), HYPERHIDROSIS (sweating), CHILLS (chills) and PYREXIA (fever). On 04-Aug-2021, the patient experienced TONGUE DISCOMFORT (tongue felt like I had burned it) and FATIGUE (Tiredness). On 05-Aug-2021, the patient experienced HYPOAESTHESIA (right side of face is numb/The right side of me face is drooping), OCULAR DISCOMFORT (cannot close right eye all of the way), DYSARTHRIA (speech is slurred) and DROOLING (excessive drooling from my mouth). At the time of the report, HYPOAESTHESIA ORAL (tongue became numb), HYPERHIDROSIS (sweating), TONGUE DISCOMFORT (tongue felt like I had burned it), HYPOAESTHESIA (right side of face is numb/The right side of me face is drooping), OCULAR DISCOMFORT (cannot close right eye all of the way), DYSARTHRIA (speech is slurred), VACCINATION SITE PAIN (Sore left injection site Arm), DROOLING (excessive drooling from my mouth), FATIGUE (Tiredness), CHILLS (chills) and PYREXIA (fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information was provided. No treatment medication were provided.